CXCL10 is pathologically involved in CM (28, –, 31) and has also been reported to play a role in central nervous system (CNS) neuronal injury, inhibition of angiogenesis, and interference with vascular endothelial growth factor (VEGF) function. This evidence concerns the gene VEGFA and cutaneous mastocytosis.